Aditxt, Inc. Operating Lease Liability
Aditxt, Inc. (ADTX) had Operating Lease Liability of $927.46 thousand as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-05-20
- 2026-03-31: Operating Lease, Liability $927.46K.
- 2025-12-31: Operating Lease, Liability $1.15M.
- 2025-09-30: Operating Lease, Liability $641.44K.
- 2025-06-30: Operating Lease, Liability $806.97K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-03-31 | $927.46K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $1.15M 10-Q · filed 2026-05-20 |
| 2025-09-30 | $641.44K 10-Q · filed 2025-11-18 |
| 2025-06-30 | $806.97K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $965.76K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.12M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.27M 10-Q · filed 2024-11-18 |
| 2024-06-30 | $1.48M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $1.79M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $2.04M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.29M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.52M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $2.97M 10-K · filed 2024-04-16 |
| 2021-09-30 | $3.79M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.86M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.17M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.25M 10-Q · filed 2021-11-15 |
| 2020-09-30 | $1.19M 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |